Stevens Capital Management LP Acadia Pharmaceuticals Inc Transaction History

Stevens Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$31.65 - $46.87 $282,286 - $418,033	-8,919 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$36.21 - $51.4 $322,956 - $458,436	8,919 New	8,919 $382,000
Q4 2018 Feb 06, 2019	SELL	$14.32 - $22.92 $826,650 - $1.32 Million	-57,727 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $67,352 - $112,735	-5,169 Reduced 8.22%	57,727 $1.2 Million
Q2 2018 Aug 09, 2018	BUY	$15.07 - $22.34 $23,765 - $35,230	1,577 Added 2.57%	62,896 $960,000
Q1 2018 May 08, 2018	BUY	$22.47 - $32.33 $62,960 - $90,588	2,802 Added 4.79%	61,319 $1.38 Million
Q4 2017 Feb 13, 2018	BUY	$26.84 - $39.14 $1.57 Million - $2.29 Million	58,517	58,517 $1.76 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.